Skip to main content

Medical Editor

Norman E. Lepor, MD, FACC, FAHA, FSCAI

Cedars-Sinai Medical Center
Known for his interest in graduate medical education and investigations in the field of interventional cardiology, Dr. Lepor is cofounder of Reviews in Cardiovascular Medicine. He is Clinical Professor of Medicine at The David Geffen School of Medicine at UCLA and an attending cardiologist at Cedars-Sinai Medical Center. He has directed investigations into the study of interventions in acute myocardial infarction, coronary artery brachytherapy, prevention of contrast nephropathy, percutaneous transmyocardial revascularization and oral antiplatelet, and anticoagulant drugs. Dr. Lepor has lectured widely on topics including the use of glycoprotein IIb/IIIa platelet receptors, contrast nephropathy, and prevention of coronary artery disease.

Peter A. McCullough, MD, MPH, FACC, FACP, FCCP, FAHA, FNKF

Baylor University Medical Center
After receiving a bachelor’s degree from Baylor University, Dr. McCullough completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School in Dallas.  He went on to complete his internal medicine residency at the University of Washington in Seattle, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan.  Dr. McCullough directs cardiovascular education and research for the Baylor Health Care System and is a Vice Chief of Medicine at Baylor University Medical Center in Dallas, TX.  He is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state with over 1000 publications.  Dr. McCullough has won numerous awards including in the Simon Dack Award from the American College of Cardiology for outstanding scholarship and the International Vicenza Award for Critical Care Nephrology for his contributions and dedication to the emerging problem of cardiorenal syndromes. 

Associate Editor

Gregg C. Fonarow MD, FACC

The David Geffen School of Medicine at UCLA
Expertise: Congestive Heart Failure An eminent specialist in heart failure management and preventative cardiology, Dr. Fonarow holds the Eliot Corday Chair in Cardiovascular Medicine and is Science Professor of Medicine, Division of Cardiology, The David Geffen School of Medicine at UCLA, Director of the Ahmanson-UCLA Cardiomyopathy Center, and Director of the UCLA Cardiology Fellowship Training Program.

Gregg W. Stone MD, FACC, FSCAI

Columbia University Medical Center
Expertise: Interventional Cardiology Dr. Stone is Professor of Medicine at Columbia University, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapies at Columbia University Medical Center, and Chairman of the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the lead principal investigator for more than 25 national and international multicenter randomized trials, and is the co-director of Transcatheter Cardiovascular Therapeutics, the world’s largest symposium devoted to interventional cardiology and vascular medicine. He directs the annual National Interventional Cardiology Fellow’s Course and numerous other annual courses. Dr. Stone’s medical practice is devoted to interventional cardiology at Columbia University Medical Center. Dr. Stone has served as has authored more than 600 book chapters, manuscripts and abstracts published in the peer-reviewed literature, and has delivered more than 1000 invited lectures around the world. Dr. Stone’s areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug eluting stents; adjunct pharmacology; new device angioplasty including distal embolic protection, thrombectomy, vascular brachytherapy and stent grafts; intravascular ultrasound imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues. 

Editorial Board Member

Alice K. Jacobs, MD, FACC, FAHA

Boston University School of Medicine
Expertise: Women and Heart Disease Dr. Jacobs is a Professor of Medicine at Boston University School of Medicine and the Director of Invasive Cardiology Services at Boston Medical Center. Her major research interest is in coronary revascularization strategies. Dr. Jacobs is the principal investigator of the MASS COMM trial, which is evaluating the safety and efficacy of coronary angioplasty performed in community hospitals without on-site cardiac surgery in Massachusetts. She is also interested in cardiovascular disease in women and the sex-based differences in the epidemiology, diagnosis, treatment, and prognosis of ischemic heart disease.

Christopher P. Cannon, MD, FACC

Harvard Medical School
Expertise: Acute Coronary Syndromes Dr. Cannon is a Professor of Medicine at Harvard Medical School, and is a senior investigator in the Thrombolysis In Myocardial Infarction (TIMI) Study Group in the Cardiovascular Division at Brigham and Women’s Hospital in Boston. He has led or is leading 14 international trials in the field of acute coronary syndromes and prevention. He is Editor-in-Chief of the journal Critical Pathways in Cardiology and Deputy Editor-in-Chief of Clinical Cardiology, as well as Editor-in-Chief of CardioSource Science and Quality, the American College of Cardiology’s Web site (www.cardiosource.org).

Dean J. Kereiakes, MD, FACC, FSCAI

Ohio State University
Expertise: New Drugs and Devices An active clinical and scientific investigator, Dr. Kereiakes is Medical Director of The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, and Professor of Clinical Medicine at Ohio State University. Dr. Kereiakes serves on the scientific advisory boards for multiple medical device companies and on the editorial boards of seven major cardiovascular journals. He maintains an active practice in interventional cardiology.

Deepak L. Bhatt, MD, MPH

Harvard Medical School
Expertise: Heart Failure Deepak L. Bhatt MD, MPH, is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School. Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2016. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. He has authored or co-authored over 900 publications and is listed as a Thomson Reuters Highly Cited Researcher. He is the Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease.

Gerald M. Pohost, MD, FACC, FAHA

University of Southern California; Loma Linda University School of Medicine
Expertise: Cardiovascular Imaging Dr. Pohost is known worldwide for his contributions to cardiovascular imaging. His pioneering efforts led to the development of thallium for clinical myocardial imaging and the field of cardiovascular magnetic resonance imaging. His leadership led to the establishment of the (International) Society for Magnetic Resonance in Medicine and the Society for Cardiovascular Magnetic Resonance. He is a Professor at the Keck School of Medicine and the Viterbi School of Engineering at the University of Southern California, and a Professor at the Loma Linda University School of Medicine. Dr. Pohost has been working on developing and applying approaches for diagnostic image analysis in China and has received professorships at three universities in China.

Karol E. Watson, MD, PhD

The David Geffen School of Medicine at UCLA
Expertise: Lipid Disorders Dr. Watson is a full-time cardiologist at The David Geffen School of Medicine at UCLA. Currently, Dr. Watson is director of the Women’s Cardiovascular Center at UCLA, Co-Director of the UCLA Program in Preventative Cardiology, and director for the Center for Cholesterol and Hypertension Management. A Principal Investigator for several large National Institutes of Health studies, Dr. Watson’s more than 80 publications and presentations have addressed many subjects including prevention of heart disease, vascular calcification, hormone replacement therapy, the metabolic syndrome, hypertension, hypercholesterolemia, and cardiovascular disease in women and African Americans.

Lori B. Daniels, MD, MAS, FACC

University of California, San Diego
Expertise: Women and Heart Disease Dr. Daniels is a Professor of Medicine and cardiologist at the University of California, San Diego, where she is the Medical Director of the Cardiovascular Care Unit. Dr. Daniels is the recipient of multiple national grants studying cardiovascular epidemiology, women’s cardiovascular health, and cardiovascular biomarkers. Her research interests focus on cardiovascular epidemiology, biomarkers, cardiovascular outcomes in young adults with a childhood history of Kawasaki Disease, and imaging in chronic thromboembolic pulmonary hypertension. She has been a principal or co-investigator for a large number of clinical studies, has given talks all over the world, and has authored or co-authored over 200 scientific papers, reviews, book chapters, and abstracts.

Maria Rosa Costanzo, MD, FACC, FAHA

Midwest Health Specialists Advocate Medical Group
Expertise: Congestive Heart Failure Dr. Costanzo is the Medical Director of the Midwest Health Specialists Advocate Medical Group Heart Failure and Pulmonary Arterial Hypertension Programs, and Medical Director of the Edward Hospital Center for Advanced Heart Failure. Dr. Costanzo has published more than 160 peer-reviewed manuscripts and is the author of numerous review papers, monographs and book chapters.

Matthew J. Price, MD, FACC, FSCAI

Scripps Clinic
Expertise: Interventional cardiology Dr. Price is an interventional cardiologist and currently serves as Director of the Cardiac Catheterization Laboratory in the Cardiovascular Division of Scripps Clinic and Assistant Professor at the Scripps Translational Science Institute. Dr. Price has published numerous papers and chapters on high-risk percutaneous coronary intervention (PCI), drug-eluting stents, and the impact of antiplatelet therapy on outcomes after stent implantation. He is involved in the leadership of several trials examining the safety and efficacy of antiplatelet therapy during and after PCI.

Michael H. Davidson, MD

University of Chicago
Expertise: Lipid Disorders Dr. Davidson is Clinical Professor and Director of Preventive Cardiology at the University of Chicago. He also serves as Chief Medical Officer for Omthera Pharmaceuticals. Dr. Davidson’s clinical research background encompasses both pharmaceutical and nutritional clinical trials. His extensive research on statins, novel lipid-lowering drugs, and nonpharmacologic risk factor reduction has established him as a key opinion leader in this area. Dr. Davidson has coordinated more than 1000 clinical trials in areas of preventive cardiology, published more than 250 articles for leading medical journals, and has written three books on lipidology.

Mikhail Kosiborod, MD, FACC, FAHA

Saint Luke’s Mid America Heart Institute
Expertise: Diabetes and heart disease Dr. Kosiborod is a cardiologist and a clinical scholar at Saint Luke’s Mid America Heart Institute, and Associate Professor of Medicine at the University of Missouri-Kansas City. His main research interests include diabetes and glucose management in patients with acute coronary syndromes. He has authored and co-authored many peer-reviewed publications and abstracts, including several scientific statements and position documents on in-hospital and long-term glucose control. Dr. Kosiborod is a recipient of several American Heart Association research awards. He is actively involved in the work of many committees for the American College of Cardiology and American Heart Association.

Nathan D. Wong, PhD, MPH, FACC, FAHA, FNLA, FASPC

University of California, Irvine
Expertise: Prevention Dr. Nathan Wong is a cardiovascular epidemiologist and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine in California, as well as Adjunct Professor of Epidemiology and UCLA and UC Irvine and Radiology at UC Irvine. Dr. Wong has primary research interests in subclinical atherosclerosis, lipid and diabetes management, and cardiovascular disease prevention and has authored over 275 papers and co-edited seven textbooks, including the Braunwald Companion on Preventive Cardiology and the ASPC Manual on Preventive Cardiology. He is a deputy editor of Global Heart and on the editorial boards of other cardiology and endocrinology journals and serves as editor of the Diabetes and Cardiometabolic Clinical Topic Collection for the American College of Cardiology. Dr. Wong is also a previous recipient of the Jan Kellermann Memorial Award for Cardiovascular Disease Prevention and Distinguished Fellowship Award from the International Academy of Cardiology. Dr. Wong lectures locally, nationally, and internationally on various topics in preventive cardiology

Paul A. Gurbel, MD

Inova Heart and Vascular Institute
Expertise: Coagulation Dr. Gurbel is Director, Inova Center for Thrombosis Research and Drug Development; Director, Interventional Cardiology and Cardiovascular Medicine Research, Inova Heart and Vascular Institute, Fairfax, VA; Professor of Medicine at the Johns Hopkins University School of Medicine; and Adjunct Professor of Medicine at Duke University School of Medicine. He specializes in the catheter-based treatment of patients with complex cardiovascular disease and he has performed over 15,000 percutaneous cardiac and peripheral procedures. His research has focused on defining the effects of antiplatelet agents, antiplatelet agent development, and understanding the relation of platelet reactivity to ischemic event occurrence in patients undergoing stenting. He holds patents in the fields of interventional cardiology and antithrombotic therapy. Dr. Gurbel serves on the editorial boards for various medical journals and on Scientific Session Committees. His concepts and research have been published in over 1000 abstracts, manuscripts, monographs, books and book chapters. He has authored over 400 major articles in peer-reviewed journals.

Peter R. Kowey, MD, FACC, FHRS, FAHA

Lankenau Hospital Institute
Expertise: Electrophysiology Dr. Kowey is the William Wikoff Smith Chair in Cardiovascular Research at Lankenau Hospital Institute and Professor of Medicine and Clinical Pharmacology at Jefferson Medical College. Dr. Kowey’s principal area of interest is cardiac rhythm disturbances. He has been the recipient of over 150 grants and has authored or co-authored over 400 papers and scientific reports. His group has participated in a large number of pivotal clinical trials, many directed by Dr. Kowey himself. He is the co-editor of 3 textbooks regarding cardiac arrhythmia. He is a referee for manuscript review for 25 journals and sits on the editorial boards of several journals including the Heart Rhythm Journal and the Journal of Cardiovascular Electrophysiology. He has provided consultation to over 80 international pharmaceutical companies and chaired several data and safety monitoring boards for clinical trials. While working with industry, he has pioneered the development of many antiarrhythmic drugs and antitachycardia devices that are used around the world for the treatment of patients with life-threatening cardiac rhythm problems. Dr. Kowey also maintains a busy consultative arrhythmia practice and has been recognized as a leader in his field in several international publications.

Prakash C. Deedwania, MD, FACC, FAHA, FACP, FCCP

University of California, San Franciso
Expertise: Heart Failure Dr. Deedwania is one of the most recognizable figures in the fields of hypertension, heart failure, lipid disorders, ischemic heart disease, rhythm disorders, and preventive cardiology. He is Professor of Medicine at the University of California San Francisco (UCSF) School of Medicine and is Chief of the Cardiology Division for the Veterans Administration Central California Health Care System. Dr. Deedwania is also Director of Cardiovascular Research for the UCSF Fresno Central San Joaquin Valley Medical Education Program and Clinical Professor of Medicine at Stanford University in Palo Alto, CA. He has authored numerous landmark clinical trials and has authored or co-authored more than 350 publications.

Prediman K. Shah, MD, FACC, FACP, FCCP

The David Geffen School of Medicine at UCLA
Expertise: Molecular Cardio-biology Dr. Shah is Director of the Division of Cardiology and Director of the Oppenheimer Atherosclerosis Research Center at Cedars-Sinai Medical Center in Los Angeles, where he holds the Shapell and Webb Family Chair in Clinical Cardiology at Cedars-Sinai. He is also Professor of Medicine at The David Geffen School of Medicine at UCLA. Dr. Shah is currently leading several studies that focus on heart disease prevention and treatment. In March, 2012, Dr. Shah received the Distinguished Scientific Achievement award (basic science category) from the American College of Cardiology. He has edited three books on heart disease and published more than 600 scientific papers, reviews, book chapters, and abstracts.

Robert J. Siegel, MD

Cedars-Sinai Medical Center
Expertise: Echocardiography Robert J. Siegel, MD is Director of the Cardiac Noninvasive Laboratory, Director of the Clinics for Hypertrophic Cardiomyopathy and Aortopathies at Cedars-Sinai Medical Center, holds the Kennamer Chair in Cardiac Ultrasound, and is Professor of Medicine at UCLA and Cedars-Sinai. He is a Fellow of the American College of Cardiology (ACC), Past President of the California Chapter of the ACC, and Past President of the Los Angeles Society of Echocardiography. Dr. Siegel has edited three medical textbooks, authored over 350 peer-reviewed papers, and is a contributing author to more than a dozen textbooks.

William T. Abraham, MD

The Ohio State University College of Medicine
Expertise: Heart Failure Dr. Abraham is Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at The Ohio State University in Columbus, OH. Dr. Abraham’s clinical activities and research interests focus on heart failure. He has received grants from the National Institutes of Health and participated in more than 100 multicenter clinical drug and device trials. In addition to authoring more than 600 original works, Dr. Abraham has co-edited a leading textbook, Heart Failure: A Practical Approach to Treatment.